Overview of Taris GemRIS, a Novel Drug Delivery System for Bladder Cancer.
Journal Article (Journal Article)
GemRIS, an implantable drug delivery system from Taris Biomedical that delivers continuous intravesical gemcitabine, shows potential for use in multiple bladder cancer settings. Ongoing and recently completed phase 1 trials in non-muscle-invasive as well as muscle-invasive bladder cancer are yielding promising preliminary results.
- Grimberg, DC; Shah, A; Inman, BA
- July 15, 2020
Volume / Issue
- 6 / 4
Start / End Page
- 620 - 622
Electronic International Standard Serial Number (EISSN)
Digital Object Identifier (DOI)